KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDeferred TaxesDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crescent Capital BDC (CCAP) Gains from Investment Securities (2022 - 2025)

Historic Gains from Investment Securities for Crescent Capital BDC (CCAP) over the last 4 years, with Q3 2025 value amounting to -$116000.0.

  • Crescent Capital BDC's Gains from Investment Securities changed N/A to -$116000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 1968.5%. This contributed to the annual value of $1.3 million for FY2024, which is 10180.45% up from last year.
  • Latest data reveals that Crescent Capital BDC reported Gains from Investment Securities of -$116000.0 as of Q3 2025.
  • Crescent Capital BDC's 5-year Gains from Investment Securities high stood at $1.7 million for Q1 2025, and its period low was -$116000.0 during Q3 2025.
  • For the 4-year period, Crescent Capital BDC's Gains from Investment Securities averaged around $696625.0, with its median value being $454500.0 (2022).
  • In the last 5 years, Crescent Capital BDC's Gains from Investment Securities crashed by 6677.12% in 2023 and then surged by 13811.32% in 2024.
  • Quarter analysis of 4 years shows Crescent Capital BDC's Gains from Investment Securities stood at $379000.0 in 2022, then crashed by 64.38% to $135000.0 in 2023, then plummeted by 40.74% to $80000.0 in 2024, then tumbled by 245.0% to -$116000.0 in 2025.
  • Its last three reported values are -$116000.0 in Q3 2025, $1.7 million for Q1 2025, and $80000.0 during Q4 2024.